Because LDLR contributes to both cholesterol and amyloid-β homeostasis, insights into the variation of LDLR and splicing regulation in different cell types of target organs may clarify the co-occurrence of cardiovascular diseases and Alzheimer’s disease. This evidence concerns the gene LDLR and early-onset autosomal dominant Alzheimer disease.